Nano-Sized Crystalline Hydroxyapatite Coating Adhesion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing and applying hydroxyapatite coatings on implants face challenges such as poor adhesion, amorphous HA formation, and thick layer deposition, leading to osseointegration issues and surgical failures due to low mechanical reliability and bioinert properties.

Innovation Solution

A method involving surfactant self-assembly and microemulsion techniques to produce nano-sized crystalline hydroxyapatite with a specific surface area of 150-300 m2/g, which can be applied as a thin, highly crystalline coating on substrates with an oxide layer, enhancing adhesion and bioactivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to produce hydroxyapatite coatings, then the coating can be applied to implants, but the adhesion is poor and the layer becomes thick, leading to detachment and surgical failure

Engineering Contradiction:
Improveadhesion of HA coatingVSAvoidthickness of HA layer
Core Design Contradiction:
ReliabilityVSLength of stationary object

Solution Approach 1:

The patent segments the hydroxyapatite into nano-sized crystalline particles (1-10 nm) rather than using conventional micro-sized particles. This segmentation at the nanoscale allows the coating to achieve high adhesion while maintaining thin layer thickness, as the nano-particles can penetrate and bond effectively with the implant substrate at the molecular level, preventing detachment without requiring thick layers.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent fundamentally changes the particle size parameter from micro-scale to nano-scale (1-10 nm), and controls the specific surface area to 150-300 m2/g. This parameter transformation enables the coating to achieve both thinness and high adhesion, as the nano-particles provide extensive surface area for bonding while maintaining a thin overall layer thickness that integrates seamlessly with the implant surface.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If conventional HA is used for implant coatings, then the material can be applied, but it forms amorphous structure instead of crystalline, reducing mechanical reliability

Engineering Contradiction:
Improvecrystallinity of HAVSAvoidmechanical reliability
Core Design Contradiction:
Stability of the object's compositionVSStrength

Solution Approach 1:

The patent changes the structural parameter from amorphous to crystalline by controlling the synthesis conditions and particle size. The nano-sized crystalline structure with controlled dimensions (1-10 nm) and specific surface area (150-300 m2/g) provides both structural stability and mechanical strength, as the crystalline phase maintains structural integrity while the nano-scale dimensions prevent excessive stress concentration that would occur in thicker amorphous layers.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite structure where nano-sized crystalline hydroxyapatite particles are distributed throughout the coating layer. This composite approach combines the crystalline stability of HA with the high surface area-to-volume ratio of nano-particles, achieving both structural stability and enhanced mechanical reliability through the synergistic effect of crystalline ordering and nanoscale geometry.

Inventive Principle:
Principle #40Composite materials

3Quantity of substance

If thick HA layers are deposited on implants, then more material is available for osseointegration, but adhesion deteriorates and detachment occurs

Engineering Contradiction:
Improveamount of HA coatingVSAvoidadhesion of HA coating
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent segments the HA coating into numerous nano-sized particles (1-10 nm) that can densely pack and bond to the implant surface. This segmentation allows the coating to provide sufficient material quantity for osseointegration while maintaining thin overall thickness and high adhesion, as the nano-particles create extensive bonding interfaces with the substrate without requiring thick layers.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the particle size parameter to nano-scale (1-10 nm) with controlled specific surface area (150-300 m2/g), which fundamentally alters how the material deposits and bonds to the implant. This parameter change enables the coating to achieve high adhesion even with sufficient material quantity, as the nano-particles distribute evenly and bond effectively at the nanoscale interface without forming detached thick layers.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method produces high-strength, bioactive hydroxyapatite coatings that promote quicker and more controlled osseointegration by mimicking natural HA in the body, improving mechanical reliability and adhesion on complex surfaces.

Implementation Method 1

A method involving surfactant self-assembly and microemulsion techniques to produce nano-sized crystalline hydroxyapatite

Methodology Applied
Scientific EffectSurfactant self-assembly: Self-Assembly

Implementation Method 2

surfactant self-assembly and microemulsion techniques to produce nano-sized crystalline hydroxyapatite

Methodology Applied
Scientific EffectMicelle formation: Microemulsion

Implementation Method 3

allowing the liquid crystalline phase to equilibrate, and placing the equilibrated liquid crystalline phase in an ammonia atmosphere to raise the pH so that nano-sized crystals of calcium phosphate are formed

Methodology Applied
Scientific EffectLiquid crystalline phase transition: Phase Change

Implementation Method 4

placing the equilibrated liquid crystalline phase in an ammonia atmosphere to raise the pH so that nano-sized crystals of calcium phosphate are formed

Methodology Applied
Scientific EffectpH-induced precipitation: Precipitation

Data Source

PatentUS8206813B2Synthetic nano-sized crystalline calcium phosphate and method of production
Publication Date: 2012.06.26 PROMIMIC
  • US8206813B2 patent drawing
  • US8206813B2 patent drawing
  • US8206813B2 patent drawing

AI summary

Synthetic nano-sized crystalline calcium phosphate, particularly hydroxyapatite, having a specific surface area in the range of 150 m2/g to 300 m2/g, is described. The nano-sized crystalline calcium phosphate may be in the form of a powder or in the form of a coating on a surface. A method of producing a nano-sized crystalline calcium phosphate powder or coating is also described. The method comprises formation of a liquid crystalline phase in a water solution of calcium, phosphor and a surfactant, placing the phase in an ammonia atmosphere so that nano-sized crystals are formed, followed by either removal of the surfactant with a solvent and recovering the nano-sized crystals to obtain the powder, or diluting the ammonia-treated liquid crystalline phase with a hydrophobic organic solvent to create a microemulsion of the nano-sized crystals in water, dipping an oxide layer-coated surface of an object into the microemulsion, or alternatively saving the step of ammonia treatment of the liquid crystalline phase until after the dipping of the surface of an object into the microemulsion, followed by removal of the organic solvent and the surfactant from the surface to obtain the coating.